ScreenCell® Technology

A circulating tumor cells test for capture CTC from blood sample.

ScreenCell® technology is based on a patented and unique microfiltration principle, enabling the isolation of circulating tumor cells (CTCs) from a simple blood sample.

The liquid biopsy technology dedicated to the detection of circulating tumor cells

ScreenCell® technology is a versatile liquid biopsy platform designed for the non-invasive detection of circulating tumor cells (CTCs) from a simple blood draw in patients with solid tumors.

It is available in seven single-use kits, each specifically designed for distinct applications in circulating tumor cell detection.

The advantages of our microfiltration technology

An isolation method validated by the scientific community

Downstream analyses available with our CTC test

Discover a multitude of downstream analyses achievable with our circulating tumor cell test and choose the one you need across our three areas of expertise: Cytology, Molecular Biology and Cell Culture.

Simplicity in your hands

ScreenCell® technology stands out from other methods due to its remarkable ease of use.

It provides users with the ability to efficiently and quickly detect circulating tumor cells (CTCs), without any machine-related constraints, in just three simple steps: dilution, filtration, and ejection.

Looking for a simple method for CTC isolation?

You’ve come to the right place!
Fill in the fields below and we’ll take care of the rest.

Want to learn more?

Download our brochure

Follow ScreenCell® on LinkedIn